Dr Reddy’s arm launches website for diabetic patients
image for illustrative purpose
Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, on Wednesday announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients. Launched by DRL’s wholly-owned subsidiary, Svaas Wellness Limited, the website will host the Celevida range of products and third-party brands that offer product portfolio for diabetic patients.
Since its launch in 2019, Celevida has been the flagship nutrition brand for dietary management of diabetes. The website currently delivers to more than 18,000 pin codes across India.
M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), said: “We are happy to announce the launch of ‘Celevida Wellness’ as a direct-to-consumer e-commerce platform by our subsidiary Svaas Wellness. We see the platform becoming a comprehensive one-stop solution for Type 2 diabetic and pre-diabetic patients offering meals, personalised dietary and health information, and in due course, features such as a digital diary to track health patterns, and on-call nutritionists.”
The CEO further said that “as a business, this launch strengthens our presence in the nutraceutical segment, and also marks our foray into the D2C space as we aim to reach more than 1.5 billion patients by the year 2030.” With ‘Celevida Wellness’, our aim will be to learn constantly and work towards offering best-in-class consumer experience. We will also be able to create capabilities that can be scaled and replicated across markets, Ramana added.
